Fresenius Kabi

A lifesaving match

A lifesaving match

Facing cancer together

Facing cancer together

Facing cancer together

Developing lifesaving medicines
and advanced technologies

Answering the challenges
medical professionals face

Applying our strength,
experience, and passion

A lifesaving match

A lifesaving match

Facing cancer together

Facing cancer together

Developing lifesaving medicines
and advanced technologies

Answering the challenges
medical professionals face

Applying our strength,
experience, and passion

News

September 3, 2019

Fresenius Kabi and AABB Celebrate 14th Annual Blood Collectors Week

Fresenius Kabi Introduces Phenylephrine Hydrochloride Injection, USP

Fresenius Kabi chooses Kenosha County for regional distribution center

Fresenius Kabi Introduces Levothyroxine Sodium Injection Solution

Fresenius Kabi Introduces Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection

Fresenius Kabi Introduces Neostigmine Methylsulfate Injection, USP Simplist® Prefilled Syringe in 3 mg per 3 mL Presentation

Premier’s ProvideGx™ Subsidiary and Fresenius Kabi Collaborate to Address Drug Shortages for Five Critical Medications

Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations

Fresenius Kabi Introduces Adenosine Injection, USP Simplist® Prefilled Syringes in 6 mg per 2 mL and 12 mg per 4 mL Presentations

Fresenius Kabi Announces Inductees to Blood Donation Hall of Fame

Fresenius Kabi and AABB Celebrate 14th Annual Blood Collectors Week

Fresenius Kabi Introduces Phenylephrine Hydrochloride Injection, USP

Fresenius Kabi chooses Kenosha County for regional distribution center

Fresenius Kabi Introduces Levothyroxine Sodium Injection Solution

Fresenius Kabi Introduces Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection

Fresenius Kabi Introduces Neostigmine Methylsulfate Injection, USP Simplist® Prefilled Syringe in 3 mg per 3 mL Presentation

Premier’s ProvideGx™ Subsidiary and Fresenius Kabi Collaborate to Address Drug Shortages for Five Critical Medications

Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations

Fresenius Kabi Introduces Adenosine Injection, USP Simplist® Prefilled Syringes in 6 mg per 2 mL and 12 mg per 4 mL Presentations

Fresenius Kabi Announces Inductees to Blood Donation Hall of Fame

EXPLORE PRODUCTS

We develop and deliver injectable drugs and delivery systems used to treat a broad spectrum of patients. Our portfolio also includes parenteral nutrition products and advanced medical devices for transfusion medicine, cell therapy lab processing and infusion.

CAREERS

As a part of Fresenius Kabi, you can enjoy an exciting career, a company culture based on a clear purpose and values, and the knowledge that your work makes a real difference. If you would like to learn more about us, we would love to hear from you.

EXPLORE PRODUCTS

CAREERS

September 16 - 17, 2019
|
USA, Concord, NC

North Carolina Association of Blood Banks

September 17 - 19, 2019
|
England, London

Phacilitate Leaders Europe 2019

Link to Event Website

September 17 - 19, 2019
|
Japan, Tokyo

3rd Cell Therapy World Asia 2019 (CTWA)

September 18 - 19, 2019
|
USA, Indianapolis, IN

Indiana State Assoc of Blood Banks (ISABB)

September 26, 2019
|
USA, Bloomington, MN

Minnesota Association of Blood Banks

September 16 - 17, 2019
|
USA, Concord, NC

North Carolina Association of Blood Banks

September 17 - 19, 2019
|
England, London

Phacilitate Leaders Europe 2019

Link to Event Website

September 17 - 19, 2019
|
Japan, Tokyo

3rd Cell Therapy World Asia 2019 (CTWA)

September 18 - 19, 2019
|
USA, Indianapolis, IN

Indiana State Assoc of Blood Banks (ISABB)

September 26, 2019
|
USA, Bloomington, MN

Minnesota Association of Blood Banks